What are the target groups of the Gene Therapy and Cell Therapy?
Target Audience of the 1st International Congress on Gene Therapy and Cell Therapy
Medical and Clinical Researchers
Specialists involved in translational and clinical research related to gene and cell-based therapies.
Molecular Biologists and Geneticists
Scientists working in genomics, molecular medicine, and gene editing technologies.
Stem Cell and Regenerative Medicine Experts
Researchers and clinicians focusing on stem cell applications and tissue engineering.
Clinical Oncologists and Hematologists
Medical professionals interested in the use of gene and cell therapies for cancer and blood disorders.
Immunologists
Researchers exploring immune cell therapies, including CAR-T and other immune-based treatments.
Pharmaceutical and Biotechnology Industry Professionals
Experts from R&D, regulatory affairs, and business development involved in the development and commercialization of advanced therapies.
Medical Doctors and Healthcare Providers
Clinicians seeking to enhance their understanding of new therapeutic options for patient care.
Regulatory Authorities and Policy Makers
Individuals involved in the regulation and oversight of advanced therapy medicinal products (ATMPs).
Ethicists and Legal Experts
Professionals exploring the ethical, legal, and societal implications of gene and cell therapies.
Postgraduate Students and Early-Career Scientists
Graduate students, PhD candidates, and young researchers aiming to deepen their knowledge and engage with the international scientific community.
Investors and Innovation Stakeholders
Venture capitalists, angel investors, and innovation hubs supporting biotech innovation and commercialization.
